Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.

Mercer, Derry K; Stewart, Colin S; Miller, Lorna; Robertson, Jennifer; Duncan, Vanessa M S; O'Neil, Deborah A

Mercer, Derry K; Stewart, Colin S; Miller, Lorna; Robertson, Jennifer; Duncan, Vanessa M S; O'Neil, Deborah A.

Afiliación

Mercer DK; NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom derry@novabiotics.co.uk deborah@novabiotics.co.uk.
Stewart CS; NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom.
Miller L; NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom.
Robertson J; NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom.
Duncan VMS; NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom.
O'Neil DA; NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom derry@novabiotics.co.uk deborah@novabiotics.co.uk.

Antimicrob Agents Chemother ; 63(5)2019 05.

Article en En | MEDLINE | ID: mdl-30858219

Asunto(s)

Antifúngicos/uso terapéutico; Onicomicosis/tratamiento farmacológico; Antifúngicos/farmacología; Arthrodermataceae/efectos de los fármacos; Arthrodermataceae/patogenicidad; Humanos; Masculino; Pruebas de Sensibilidad Microbiana; Microscopía Electroquímica de Rastreo; Uñas/microbiología; Onicomicosis/microbiología; Tiña/tratamiento farmacológico; Tiña/microbiología

Palabras clave

antifungal agents; antifungal susceptibility testing; antimicrobial peptides; dermatophytes; onychomycosis; tinea

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Onicomicosis / Antifúngicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google